Christina Caso joined the research team of the ADRC in 2016. She came from Massachusetts General Hospital's Frontotemporal Degeneration (FTD) Unit, where she worked with Dr. Brad Dickerson's lab on research to understand the relationships between brain anatomy and function in individuals with FTD and other neurodegenerative diseases, particularly FTD. FTD is a spectrum of non-Alzheimer neurodegenerative diseases that progressively impact motor function, language, and/or behavior.
Caso currently works on the Therapeutic Pipeline Project's Dynamic Functional Connectivity MRI in Preclinical AD, an imaging study led by Dr. Thomas Grabowski and Tara Madhyastha, PhD., to evaluate the potential of MRI and PET scans to serve as a tool of diagnosis or to track disease progression. She helps conduct the study visits for the participating subjects in the ADRC cohort, operate the MRI machine, and perform quality control on the scan.
She helps run the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) study. IDEAS, led at the UW by Dr. Kimiko Domoto-Reilly, is assessing the clinical usefulness of amyloid PET scans, which can serve to differentiate possible Alzheimer disease from other disorders and therefore help physicians to provide accurate diagnosis.
She also belongs to the research team in the UW Integrated Brain Imaging Center (IBIC), helping to process structural MRI brain scans.
Alzheimer's disease dementia, frontotemporal degeneration, MRI and PET technologies, neuropsychology, working with patients and families